Merck is an A+ credit, a global oncology powerhouse, and still, about half its 2024 pharma revenue came from a…
The pharmaceutical industry heads into 2026 carrying strong M&A momentum, a surging Chinese deal landscape and continued buzz around obesity…
Pfizer has filed two lawsuits against the metabolic-focused startup Metsera and Novo Nordisk as of Tuesday. The first suit, filed…
Sign in to your account
Remember me
